Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Cardiac Decompensation
Age: Adult
Dose: Intravenous continuous infusion – 0.5-1 mcg/kg/min initially, then 2-20 mcg/kg/min
Note: Not to exceed 40 mcg/kg/min. Adjust according to patient's blood pressure, heart rate, cardiac and urine output.

Child Dose

Clinical InformationAdministration Information
Indication: Cardiac Decompensation
Dose: Intravenous continuous infusion – 0.5-1 mcg/kg/min
Note: initially
Indication: Cardiac Decompensation
Dose: Intravenous continuous infusion – 2-20 mcg/kg/min
Note: not to exceed 40 mcg/kg/min
Administration
  • Hospital use only
  • Given via IV
Side Effect

Drug Interaction

Drug NameRisk Factors
Nitroprusside
Increased cardiac output
Bretylium, Guanethidine, Oxytocic drugs, TCAs
Increased vasopressor effect

Disease Interaction

Disease NameRisk Factors
Idiopathic Hypertrophic Subaortic Stenosis
Can worsen obstruction

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 15-30° C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.